Genetic Assessment of the Patients With Metabolic Syndrome

Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01268696

Acronym

GENMetS

Enrollment

300

Registered

2010-12-31

Start date

2010-12-31

Completion date

2015-01-31

Last updated

2011-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

diabetes, obesity, hypertension, dyslipidemia

Brief summary

Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are: weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.

Detailed description

Eligibility criteria to the study: * patients with metabolic syndrome * with written consent

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Yes

Inclusion criteria

* patients with metabolic syndrome according to IDF,AHA and NHLBI 2009

Exclusion criteria

* diabetes type 1 * cancer * not consent * steroid therapy * alcohol or drug abuse * chronic inflammatory disease * pregnancy or lactation * severe hypothyroidism * immunosuppressive treatment * operation or severe injury during the last month

Countries

Poland

Outcome results